You are here

CAR-T

7 Areas to watch from the ASCO abstracts

BioPharma Dive

Fri, 05/19/17 - 11:35 am

NewLink Genetics

Juno Therapeutics

After Kite Pharma stuns analysts with news of a death in lead CAR-T study, safety questions sour launch forecast

Endpoints

Tue, 05/9/17 - 10:23 am

One of Kite Pharma’s CAR-T patients died from cerebral edema, triggering a safety alarm

Endpoints

Mon, 05/8/17 - 11:33 am

Juno Therapeutics

Novartis takes the long view on CAR-T, grabbing licenses on new tech for next-gen therapies

Endpoints

Wed, 05/3/17 - 10:05 am

Novartis Snags Coveted FDA 'Breakthrough' Label for CAR-T, Trial Results Still Under Wraps

TheStreet.com

Tue, 04/18/17 - 09:49 am

breakthrough status

Why Juno Therapeutics Stock Slumped in March

Motley Fool

Sun, 04/9/17 - 12:17 pm

Juno Therapeutics

Kite Pharma hits its Q1 deadline on filing a BLA for its pioneering CAR-T, posts improved data

Endpoints

Fri, 03/31/17 - 10:06 pm

non-Hodgkin's lymphoma

Novartis Makes Plans For Its Cancer-Killing T Cells

Forbes

Wed, 03/29/17 - 10:35 pm

The ABCs of Juno's failed flagship drug trial

Bizjournals.com

Sat, 03/11/17 - 11:52 am

Juno Therapeutics

clinical trials

Servier, Pfizer get FDA OK to start US testing of an off-the-shelf CAR-T from Cellectis

Endpoints

Thu, 03/9/17 - 11:34 am

acute lymphocytic leukemia

Bad News Biotechs: What's Next for Juno and PTC Therapeutics?

Motley Fool

Mon, 03/6/17 - 09:40 am

Juno Therapeutics

PTC Therapeutics

cystic fibrosis

Juno ends flagship drug trial after deaths and FDA suspensions

Bizjournals.com

Wed, 03/1/17 - 08:59 pm

Juno Therapeutics

clinical trials

acute lymphoblastic leukemia

Kite Pharma reports positive results from non-Hodgkins lymphoma drug study

Marketwatch

Tue, 02/28/17 - 11:08 am

non-Hodgkins lymphoma

Novartis Out To Prove Its Oncology Doubters Wrong

Seeking Alpha

Sat, 01/28/17 - 02:22 pm

Fighting a generic onslaught, Novartis adds CAR-T to its growing list of late-stage blockbusters

Endpoints

Wed, 01/25/17 - 09:55 am

Novartis chief Jimenez touts two top PhIII drug prospects

Endpoints

Wed, 01/18/17 - 10:07 am

multiple sclerosis

Kite Pharma partners with Japan's Daiichi for cancer therapy

Yahoo/Reuters

Tue, 01/10/17 - 11:11 am

axicabtagene ciloleucel

Fortress Bio soars after reporting breakthrough with CAR-T cancer approach

Marketwatch

Thu, 12/29/16 - 10:22 am

Fortress Biotech

CAR-T therapy makes early inroads in treating brain cancer

Stat

Wed, 12/28/16 - 07:35 pm

Juno Therapeutics Defeats Kite Pharma’s Challenge to CAR T-Cell Patent

Yahoo

Mon, 12/19/16 - 11:41 am

Juno Therapeutics

Pages